Apollo Hospitals Enterprises Ltd, a prominent player in the healthcare sector, witnessed a decline of almost 47% in its consolidated net profit for the quarter ending in June, compared to the same period the previous year. The downturn in net profit was attributed to one-off factors that impacted the company’s financial performance.

Despite this decline, Apollo Hospitals’ healthcare services division, particularly its hospitals segment, exhibited robust performance. Analysts are optimistic about the company’s outlook, as the hospitals division played a crucial role in sustaining a positive trajectory for the company.

The healthcare industry has been subject to various challenges and disruptions due to the ongoing global circumstances. Apollo Hospitals’ emphasis on delivering quality healthcare services has enabled it to maintain a strong position in the sector. While the one-off factors influenced the overall net profit figures, the company’s strategic focus on its core operations has bolstered its performance in the healthcare services domain.

Apollo Hospitals' focus on healthcare segment fuels positive outlook | Mint

As Apollo Hospitals continues to navigate through the evolving landscape of the healthcare sector, its commitment to providing quality medical services remains a cornerstone of its strategy. The positive outlook driven by the hospitals division underscores the company’s resilience and adaptability in addressing the unique challenges faced by the industry.

Apollo Hospitals’ hospital segment continues to demonstrate resilience and strong performance. The average revenues per operating bed (ARPOB) stood at ₹57,760, marking an impressive increase of 11% compared to the previous year. Moreover, the segment’s profits surged by 19% year-on-year, reaching ₹264 crore.

Despite the challenges posed by various factors, including the global health situation, the hospital segment has maintained its positive momentum. The reported ARPOB growth highlights the effectiveness of Apollo Hospitals’ strategies in optimizing revenue generation from its operating beds. This growth is indicative of the company’s ability to provide high-quality medical services that resonate with patients.

Apollo Hospitals has outlined an ambitious plan to further enhance its occupancy rates. Currently standing at 62%, the company aims to surpass the 70% mark over the next two years. This aspiration underscores the company’s confidence in its ability to attract patients and provide them with superior healthcare services.

The positive trends in ARPOB and segment profits reflect the hospital segment’s sound financial health and efficient operational management. As Apollo Hospitals continues to focus on expanding its patient base and optimizing its services, the company is poised to reinforce its position as a leading player in the healthcare sector.

The analysts at Motilal Oswal Financial Services have expressed a positive outlook on Apollo Hospitals, citing several factors that contribute to their confidence in the company’s future prospects. One of the primary reasons for their optimism is Apollo Hospitals’ consistent and healthy growth as well as profitability within the healthcare services sector.

The sustained growth and profitability in healthcare services underscore Apollo Hospitals’ effective strategies and strong market position. This performance reflects the company’s ability to adapt to changing dynamics and provide high-quality medical services that meet the needs of patients.

Another key factor that bolsters the analysts’ confidence is Apollo Hospitals’ strategic efforts to achieve breakeven in its Healthco division during the fourth quarter of FY24. This initiative signifies the company’s commitment to optimizing its operations and maximizing its financial performance. By working towards breakeven, Apollo Hospitals demonstrates its dedication to enhancing efficiency and achieving sustainable financial results.

Overall, the analysts at Motilal Oswal Financial Services highlight Apollo Hospitals’ consistent growth, profitability, and strategic initiatives as factors that position the company favorably for the future. These positive indicators reinforce their positive outlook on the company’s performance and potential for success in the healthcare sector.

Apollo Hospitals’ new hospitals are poised to experience a significant boost in volumes, with double-digit growth expected. During the first quarter, these new hospitals exhibited higher revenue growth at 23%, accompanied by margins of approximately 16.7%. The company is actively working towards achieving a target of 20% margins by the end of the year. This margin enhancement is anticipated to be driven by multiple factors, including the increasing influx of international patients and the recovery of medical tourism revenues to pre-COVID levels.

The company’s growth trajectory is further supported by the retail and insurance segments, which have demonstrated impressive year-on-year growth at 21%, surpassing the overall healthcare services growth rate of 13%. This diversified revenue stream contributes to Apollo Hospitals’ overall financial health and stability.

In line with its growth strategy, Apollo Hospitals has plans to expand its infrastructure by adding 2,000 beds across key metropolitan areas over the next four years, with an investment exceeding ₹3000 crore. This strategic expansion reflects the company’s commitment to meeting the growing demand for high-quality healthcare services in urban centers.

Pharmacy Restructuring For Growing Stores, Revenue: Apollo Hospitals

Apollo Hospitals’ emphasis on specialized medical services, including cardiac, oncology, neurology, nephrology, gastroenterology, and orthopedics, continues to be a major driver of growth. These specialties collectively contribute to 63% of the company’s inpatient revenues, underscoring the strategic importance of providing advanced medical care in these fields.

Overall, Apollo Hospitals’ comprehensive approach to growth, coupled with its focus on specialized services and strategic expansion, positions the company well for sustained success in the healthcare sector.

Apollo Hospitals’ financial performance in the first quarter was influenced by various factors, including higher costs and operating losses at its wholly-owned subsidiary, Apollo HealthCo Ltd. (AHLL). AHLL encompasses the pharmacy distribution business and the digital healthcare services platform Apollo 24×7. Although AHLL experienced elevated costs and incurred a loss in the first quarter, there is an optimistic outlook for improvement in the coming months.

The online pharmacy business has encountered increased costs over the past year, but a positive trend of decreasing costs sequentially has been observed. On the other hand, the offline pharmacy business has maintained a strong performance with margins of 6%, which are contributing to profits that will be allocated for investments in the online pharmacy sector. The online pharmacy segment is perceived as a significant growth driver for the future.

Higher Employee Stock Ownership Plan (ESOP) charges and increased costs at AHLL also had an impact on Q1 net profit. As a result, the earnings before interest, tax, depreciation, and amortization (EBITDA) saw a year-on-year growth of 4% to ₹509 crore, with a margin of 11.52%. This is compared to ₹491 crore with a margin of 12.93% in the corresponding quarter of the previous year.

Apollo Hospitals is addressing these challenges by focusing on reducing costs, enhancing the performance of AHLL, and optimizing its operations. With a clear strategy in place and measures to improve the financial performance of its subsidiaries, Apollo Hospitals aims to achieve sustained growth and profitability in the coming quarters.

Apollo Hospitals reported a net profit of ₹167 crore for the first quarter of the fiscal year 2023-24 (Q1FY24), marking a decline of 47% compared to the same period the previous year. However, when adjusted for a tax credit of ₹146.6 crore in the year-ago quarter, the net profit decline was more modest, coming in at 2% lower than the adjusted net profit of ₹171 crore in Q1 FY23.

Despite this performance, Apollo Hospitals’ stock experienced a 1.5% decrease in early Monday trading, a day when broader market indices were down by half a percent.

Apollo Hospitals: A USD 2 Billion health empire run by four sisters makes a comeback- The New Indian Express

Analysts at Jefferies India Pvt Ltd have upheld their positive ratings for Apollo Hospitals, citing factors such as increasing occupancy rates in newer hospitals and the growth of Average Revenues Per Operating Bed (ARPOB). These aspects are expected to contribute to double-digit growth for the company, thus maintaining an optimistic outlook for its future performance.